Cannabis Strategic Ventures (NUGS) Stock Price, News & Analysis

Company Overview

Cannabis Strategic Ventures, Inc. (OTCMKTS: NUGS) is a publicly traded strategic development and investment firm focused on the regulated cannabis industry. The company specializes in identifying, structuring and executing investment opportunities along the cannabis supply chain. Through its corporate advisory practice, CSV provides guidance on licensing, market‐entry strategies and operational best practices for cultivators, processors and retailers. By leveraging relationships with capital providers and regional operators, the firm seeks to accelerate growth for its portfolio companies.

In addition to advisory services, Cannabis Strategic Ventures pursues equity positions in early‐stage and growth‐phase businesses operating within the cannabis ecosystem. Its investment strategy encompasses ancillary service providers, technology platforms and health and wellness brands in both medical and adult‐use markets. CSV emphasizes capital‐efficient structures, joint‐venture alignments and licensing partnerships designed to optimize compliance and scalability. A rigorous due diligence process assesses market dynamics, regulatory landscapes and operational performance benchmarks.

Headquartered in the United States, CSV primarily serves key domestic markets while monitoring legislative developments in international jurisdictions to inform its strategic outlook. The management team combines expertise in finance, regulatory affairs and cannabis operations to bridge traditional capital markets with the evolving cannabis sector. As industry regulations and consumer preferences continue to develop, Cannabis Strategic Ventures aims to leverage its integrated advisory and investment platform to support sustainable growth in the global cannabis market.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0003
• Volume: 1,100 shs
• Average Volume: 449,750 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NUGS Stock Analysis - Frequently Asked Questions

How have NUGS shares performed this year?

Cannabis Strategic Ventures' stock was trading at $0.0001 on January 1st, 2025. Since then, NUGS shares have increased by 0.0% and is now trading at $0.0001.

How do I buy shares of Cannabis Strategic Ventures?

Shares of NUGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cannabis Strategic Ventures own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Strategic Ventures investors own include Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Tilray Brands (TLRY), Aurora Cannabis (ACB), Canopy Growth (CGC), Cresco Labs (CRLBF) and Cronos Group (CRON).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:NUGS
• CIK: 1290504
• Web: www.cannabisstrategic.com
• Phone: (310) 359-6860
• Fax: N/A
• Employees: 30
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A